Alemán OOF, Sosa PEM, Fuentes FMJ, Islas MCD

Idioma: Español
Referencias bibliográficas: 29
Paginas: 30-33
Archivo PDF: 229.30 Kb.

RESUMEN

La linfadenitis cervical causada por Mycobacterium bovis es una patología subdiagnosticada entre la población rural adulta, con factores de riesgo asociados a bajo nivel socioeconómico, situación por la cual es de suma importancia la diferenciación de otras micobacterias debido a la farmacorresistencia particular de cada entidad. M. bovis ha demostrado resistencia natural a la pirazinamida, por lo que la determinación específica de la sensibilidad antimicrobiana es fundamental para la instauración de un tratamiento efectivo. El presente reporte de caso muestra a un paciente con linfadenopatía por M. bovis resistente a estreptomicina, y fundamenta la necesidad de obtener un diagnóstico precoz para establecer un tratamiento efectivo.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Forrellad, M.A., Klepp, L.I., Gioffré, A., Sabio y García, J., Morbidoni, H.R., Santangelo, M.D.L. et al., “Virulence factors of the Mycobacterium tuberculosis complex”, Virulence, 2013, 4 (1): 3-66.

2. Brosch, R., Gordon, S.V., Marmiesse, M., Brodin, P., Buchrieser, C., Eiglmeier, K. et al., “A new evolutionary scenario for the Mycobacterium tuberculosis complex”, Proc Natl Acad Sci USA, 2002, 99: 3684-3689.

3. World Health Organization, “Global Health Observatory Data: Tuberculosis”, World Health Organization, 2015 (http://www.who.int/gho/tb/en/).

4. Müller, B., Dürr, S., Alonso, S., Hattendorf, J., Laisse, C.J., Parsons, S.D. et al., “Zoonotic Mycobacterium bovis- induced tuberculosis in humans”, Emerg Infect Dis, 2013, 19 (6): 899-908.

5. Cicero, R., Olivera, H., Hernández-Solís, A., Ramírez-Casanova, E. y Escobar-Gutiérrez, A., “Frequency of Mycobacterium bovis as an etiologic agent in extrapulmonary tuberculosis in hiv-positive and negative Mexican patients”, Eur J Clin Microbiol Infect Dis, 2009, 28: 455-460.

6. Pérez-Guerrero, L., Milian-Suazo, F., Arriga-Díaz, C., Romero- Torres, C. y Escartin-Chávez, M., “Epidemiología molecular de las tuberculosis bovina y humana en una zona endémica de Querétaro, México”, Salud Pública Mex, 2008, 50: 286-291.

7. Centers for Disease Control and Prevention, “Human tuberculosis caused by Mycobacterium bovis —New York City, 2001-2004”, Morb Mortal Wkly Rep, 2005, 54: 605-608.

8. Rodwell, T.C., Moore, M., Moser, K.S., Brodine, S.K. y Strathdee, S.A., “Tuberculosis from Mycobacterium bovis in binational communities, United States”, Emerg Infect Dis, 2008, 14: 909-916.

9. Bartralot, R., Pujol, R.M., García-Patos, V., Sitjas, D., Martin- Casabona, N., Coll, P. et al., “Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts”, J Cutan Pathol, 2000, 27 (3), 124-129.

10. Scorpio, A. y Zhang, Y., “Mutations in pnca, a gene encoding pyrazinamidase/ nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus”, Nat Med, 1996, 2: 662e7.

11. Wedlock, D.N., Skinner, M.A., DeLisle, G.W. y Buddle, B.M., “Control of Mycobacterium bovis infections and the risk to human populations”, Microbes Infect, 2002, 4: 471-480.

12. Ryan, T.J., Livingstone, P.G., Ramsey, D.S., De Lisle, G.W., Nugent, G., Collins, D.M. y Buddle, B.M., “Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: the experience from New Zealand”, Vet Microbiol, 2006, 112: 211-219.

13. Clifton-Hadley, R.S., Wilesmith, J.W., Richards, M.S., Upon, P. y Johnston, S., “The occurrence of Mycobacterium bovis infection in cattle in and around an area subset to extensive badger (Meles meles) control”, Epidemiol Infect, 1995, 114: 179-193.

14. De Lisle, G.W., Mackintosh, C.G. y Bengis, R.G., “Mycobacterium bovis in free-living and captive wildlife, including farmed deer”, Rev Sci Tech, 2001, 20: 86-111.

15. Davies, P.D., “Tuberculosis in humans and animals: are we a threat to each other?”, J R Soc Med, 99, 2006: 539-540.

16. Suzuki, Y., Matsuba, T. y Nakajima, C., “Zoonotic aspects of tuberculosis caused by Mycobacterium bovis”, Kekkaku, 2010, 85 (2): 79-86.

17. Gallivan, M., Shah, N. y Flood, J., “Epidemiology of human Mycobacterium bovis disease, California, USA, 2003-2011”, Emerg Infect Dis, 2015, 21 (3): 435-443.

18. Milian, F., Sánchez, L.M., Toledo, P., Ramírez, C. y Santillán, M.A., “Descriptive study of human and bovine tuberculosis in Querétaro, Mexico”, Rev Latinoam Microbiol, 2000, 42: 9-13.

19. Joint Tuberculosis Committee of the British Thoracic Society, “Control and prevention of tuberculosis in the United Kingdom: code of practice 2000”, Thorax, 2000, 55 (11): 887-901.

20. Hlavsa, M.C., Moonan, P.K., Cowan, L.S., Navin, T.R., Kammerer, J.S., Morlock, G.P. et al., “Human tuberculosis due to Mycobacterium bovis in the United States, 1995- 2005”, Clin Infect Dis, 2008, 47 (2): 168-175.

21. Menon, K., Bem, C., Gouldesbrough, D. y Strachan, D.R., “A clinical review of 128 cases of head and neck tuberculosis presenting over a 10-year period in Bradford, UK”, J Laryngol Otol, 2007, 121 (4): 362-368.

22. Hughes, V.M., Skuce, R., Doig, C., Stevenson, K., Sharp, J.M. y Watt, B., “Analysis of multidrug-resistant Mycobacterium bovis from three clinical samples from Scotland”, Int J Tuberc Lung Dis, 2003, 7: 1191e8.

23. Rivero, A., Márquez, M., Santos, J., Pinedo, A., Sánchez, M.A., Esteve, A., Samper, S. y Martin, C., “High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain b”, Clin Infect Dis, 2001, 32: 159e61.

24. Gori, A., Marchetti, G., Catozzi, L., Nigro, C., Ferrario, G., Rossi, M.C., Degli Esposti, A., Orani, A. y Franzetti, F., “Molecular epidemiology characterization of a multidrug- resistant Mycobacterium bovis outbreak amongst hiv-positive patients”, aids, 1998, 12: 445e6.

25. Bruijnesteijn, E.S., Lindeboom, J.A., Prins, J.M., Peeters, M.F., Claas, E.C. y Kuijper, E.J., “Real-time pcr assay using fine-needle aspirates and tissue biopsy specimen for rapid diagnosis of mycobacterial lymphadenitis in children”, J Clin Microbiol, 2004, 42 (6): 2644-2650.

26. LoBue, P.A. y Moser, K.S., “Treatment of Mycobacterium bovis infected tuberculosis patients: San Diego County, CA, US 1994-2003”, Mem. Inst. Oswaldo Cruz, 2004, 99 (7): 749-752.

27. Ammari, F., Ashraf, H., Kamal, I. y Ghariebeh, F., “Tuberculosis of the lymph glands of the neck: a limited role for surgery”, Otolaryngol Head Neck Surg, 2003, 128: 576-580.

28. National Institute for Health and Clinical Excellence, Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for its Prevention and Control, Londres, nice, 2006.

29. Harris, L., Modayil, P., Adam, J., Sharland, M., Heath, P., Planche, T. y Daya, H., “Cervicofacial ontuberculous Mycobacterium lymphadenitis in children: is surgery always necessary?”, Int J Pediatr Otorhinolaryngol, 2009, 73 (9): 1297-1301.